切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2025, Vol. 21 ›› Issue (02) : 151 -156. doi: 10.3877/cma.j.issn.1673-5250.2025.02.005

专题论坛

子宫血管周上皮细胞瘤诊疗的研究现状
王茹倩1, 罗红1,(), 曹威特1   
  1. 1. 四川大学华西第二医院超声科、出生缺陷与相关妇儿疾病教育部重点实验室,成都 610041
  • 收稿日期:2024-11-09 修回日期:2025-03-09 出版日期:2025-04-01
  • 通信作者: 罗红
  • 基金资助:
    四川省科技厅重点项目(2022YFS0086)

Current research status on diagnosis and treatment of uterine perivascular epithelioid cell tumor

Ruqian Wang1, Hong Luo1,(), Weite Cao1   

  1. 1. Department of Ultrasonic Medicine,Key Laboratory of Birth Defects and Related Diseases of Women and Children(Sichuan University),Ministry of Education,West China Second University Hospital,Sichuan University,Chengdu 610041,Sichuan Province,China
  • Received:2024-11-09 Revised:2025-03-09 Published:2025-04-01
  • Corresponding author: Hong Luo
引用本文:

王茹倩, 罗红, 曹威特. 子宫血管周上皮细胞瘤诊疗的研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2025, 21(02): 151-156.

Ruqian Wang, Hong Luo, Weite Cao. Current research status on diagnosis and treatment of uterine perivascular epithelioid cell tumor[J/OL]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2025, 21(02): 151-156.

子宫血管周上皮细胞瘤(PEComa)是一种罕见的间叶性肿瘤,具有独特的组织学、免疫组织化学和遗传学特征,临床表现无特异性,影像学特征不典型,术前诊断困难,而且容易被临床误诊为子宫肌瘤、子宫肉瘤或其他子宫肿瘤。文献报道的子宫PEComa患者例数较少,迄今对其尚无统一诊疗规范、共识可供参考,目前手术是其首选治疗方法,辅助治疗疗效迄今尚存在争议,使用雷帕霉素靶蛋白(m TOR)抑制剂对其进行靶向治疗,似乎取得较好临床疗效。笔者拟就PEComa起源、定义、流行病学特征及病因,以及子宫PEComa特点、分类标准、临床表现、影像学诊断和鉴别诊断与子宫PEComa治疗的最新研究现状进行阐述,旨在为该病的后续研究提供参考。

Uterine perivascular epithelioid cell tumor (PEComa)is a rare mesenchymal neoplasm characterized by distinctive histological,immunohistochemical,and genetic features,along with non-specific clinical manifestations and atypical imaging characteristics.Preoperative diagnosis is arduous,and it is frequently misdiagnosed as uterine fibroids,uterine sarcoma,or other uterine tumors.To date,only a limited number of cases of uterine PEComa have been reported,and there is no standardized consensus on diagnosis and treatment of PEComa.Surgery remains the preferred treatment option,and the efficacy of adjuvant therapy is still controversial.Nevertheless,recently,targeted therapy with mechanistic target of rapamycin (m TOR)inhibitors appears to have achieved superior efficacy.The author intends to elaborate on the origin,definition,epidemiological characteristics and causes of PEComa,as well as the characteristics,classification criteria,clinical manifestations,imaging diagnosis and differential diagnosis of uterine PEComa,and the latest research status of uterine PEComa treatment,aiming to provide reference for subsequent research on this disease.

[1]
Zebrowski K,Chapel DB.Perivascular epithelioid cell tumor(PEComa)of the female genital tract[J].Int J Gynecol Cancer,2023,33(7):1160-1161.DOI:10.1136/ijgc-2022-004212.
[2]
Wilhite AM,Dal Zotto V,Pettus P,et al.Perivascular epithelioid cell tumor (PEComa)of the uterus:challenges of pregnancy in determining prognosis and optimal treatment[J].Gynecol Oncol Rep,2022,40(1):100962.DOI:10.1016/j.gore.2022.100962.
[3]
Cui Q,Li C,Huang T,et al.Systematic analysis of perivascular epithelioid cell neoplasms in the female reproductive tract:a comprehensive review [J].Future Oncol,2024,20(5):283-295.DOI:10.2217/fon-2023-0778.
[4]
Katsakhyan L,Shahi M,Eugene HC,et al.Uterine leiomyosarcoma associated with perivascular epithelioid cell tumor:a phenomenon of differentiation/dedifferentiation and evidence suggesting cell-of-origin[J].Am J Surg Pathol,2024,48(6):761-772.DOI:10.1097/PAS.00000000 00002208.
[5]
Bonetti F,Pea M,Martignoni G,et al.PEC and sugar[J].Am J Surg Pathol,1992,16(3):307-308.DOI:10.1097/00000478-199203000-00013.
[6]
Zamboni G,Pea M,Martignoni G,et al.Clear cell"sugar"tumor of the pancreas.A novel member of the family of lesions characterized by the presence of perivascular epithelioid cells[J].Am J Surg Pathol,1996,20(6):722-730.DOI:10.1097/00000478-199606000-00010.
[7]
Papoutsis D,Sahu B,Kelly J,et al.Perivascular epithelioid cell tumour and mesonephric adenocarcinoma of the uterine cervix:an unknown co-existence[J].Oxf Med Case Reports,2019,2019(1):omy115.DOI:10.1093/omcr/omy115.
[8]
CaliòA,Brunelli M,Segala D,et al.Angiomyolipoma of the kidney:from simple hamartoma to complex tumour[J].Pathology,2021,53(1):129-140.DOI:10.1016/j.pathol.2020.08.008.
[9]
Yan J,Zhou D,Wang Y,et al.A retrospective clinical analysis of 11 cases of PEComa from different sites[J].World J Surg Oncol,2024,22(1):116.DOI:10.1186/s12957-024-03349-x.
[10]
Sharma A,Sharma R,Bala J,et al.Malignant perivascular epithelioid cell tumor of ovary:a rare case report[J].J Midlife Health,2025,16(1):107-109.DOI:10.4103/jmh.jmh_157_24.
[11]
Bennett JA,Braga AC,Pinto A,et al.Uterine PEComas:a morphologic,immunohistochemical,and molecular analysis of 32 tumors[J].Am J Surg Pathol,2018,42(10):1370-1383.DOI:10.1097/PAS.0000000000001119.
[12]
Garzon S,CaliòA,Ferrari FA,et al.Uterine perivascular epithelioid cell tumors (PEComa)and the accuracy of proposed classification systems in predicting the malignant versus non-malignant behavior[J].Gynecol Oncol,2024,188(1):35-43.DOI:10.1016/j.ygyno.2024.06.007.
[13]
Folpe AL,Mentzel T,Lehr HA,et al.Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin:a clinicopathologic study of 26 cases and review of the literature[J].Am J Surg P athol,2005,29(12):1558-1575.DOI:10.1097/01.pas.0000173232.22117.37.
[14]
Kudela E,Biringer K,Kasajova P,et al.Perivascular epithelioid cell tumors of the uterine cervix[J].Pathol Res Pract,2016,212(8):667-671.DOI:10.1016/j.prp.2016.03.010.
[15]
Çelik H,Kefeli M,Çetinkaya M,et al.Perivascular epithelioid cell tumor (PEComa)of the uterine cervix in a patient with tuberous sclerosis complex:a literature review[J].Turk Patoloji Derg,2018,34(1):82-86.DOI:10.5146/tjpath.2014.01274.
[16]
Fadare O.Uterine PEComa:appraisal of a controversial and increasingly reported mesenchymal neoplasm[J].Int Semin Surg Oncol,2008,5(1):7.DOI:10.1186/1477-7800-5-7.
[17]
Hu D,Miao M,Zhou H,et al.A case report of malignant perivascular epithelioid cell tumors of the uterus and literature review[J].Int J Womens Health,2024,16(1):619-628.DOI:10.2147/IJWH.S453226.
[18]
Fang CL,Lin YH,Chen WY.Microscopic endometrial perivascular epithelioid cell nodules:a case report with the earliest presentation of a uterine perivascular epithelioid cell tumor[J].Diagn Pathol,2012,7(1):117.DOI:10.1186/1746-1596-7-117.
[19]
Fadare O.Perivascular epithelioid cell tumor (PEComa)of the uterus:an outcome-based clinicopathologic analysis of 41 reported cases[J].Adv Anat Pathol,2008,15(2):63-75.DOI:10.1097/PAP.0b013e31816613b0.
[20]
Schoolmeester JK,Howitt BE,Hirsch MS,et al.Perivascular epithelioid cell neoplasm (PEComa)of the gynecologic tract:clinicopathologic and immunohistochemical characterization of 16 cases[J].Am J Surg Pathol,2014,38(2):176-188.DOI:10.1097/PAS.0000000000000133.
[21]
Bennett JA,Pinto A.The "other"uterine mesenchymal neoplasms:recent developments and emerging entities[J].Adv Anat Pathol,2024,31(6):380-396.DOI:10.1097/PAP.0000000000000440.
[22]
Kertowidjojo EC,Bennett JA.Update on uterine mesenchymal neoplasms[J].Surg Pathol Clin,2022,15(2):315-340.DOI:10.1016/j.path.2022.02.008.
[23]
Bennett JA,Oliva E.Perivascular epithelioid cell tumors(PEComa)of the gynecologic tract[J].Genes Chromosomes Cancer,2021,60(3):168-179.DOI:10.1002/gcc.22908.
[24]
Kundu R,Saha PK,Dey P.Sclerosing perivascular epithelioid cell tumor of the uterus:a rare entity posing diagnostic challenge[J].J Midlife Health,2022,13(4):328-330.DOI:10.4103/jmh.jmh_120_22.
[25]
Selenica P,Conlon N,Gonzalez C,et al.Genomic profiling aids classification of diagnostically challenging uterine mesenchymal tumors with myomelanocytic differentiation[J].Am J Surg Pathol,2021,45(1):77-92.DOI:10.1097/PAS.0000000000001572.
[26]
Liu CH,Chao WT,Lin SC,et al.Malignant perivascular epithelioid cell tumor in the female genital tract:preferred reporting items for systematic reviews and Meta-analyses[J].Medicine(Baltimore),2019,98(2):e14072.DOI:10.1097/MD.0000000000014072.
[27]
Schoolmeester JK,Dao LN,Sukov WR,et al.TFE3 translocation-associated perivascular epithelioid cell neoplasm(PEComa)of the gynecologic tract:morphology,immunophenotype,differential diagnosis[J].Am J Surg Pathol,2015,39 (3):394-404.DOI:10.1097/PAS.0000000000000349.
[28]
Cao B,Huang Y.Malignant perivascular epithelioid cell tumor (PEComa)of the uterus[J].BMC Womens Health,2022,22(1):523.DOI:10.1186/s12905-022-02119-9.
[29]
Giannella L,Delli Carpini G,Montik N,et al.Ultrasound features of a uterine perivascular epithelioid cell tumor(PEComa):case report and literature review[J].Diagnostics(Basel),2020,10(8):553.DOI:10.3390/diagnostics 10080553.
[30]
Gadducci A,Zannoni GF.Perivascular epithelioid cell tumors(PEComa)of the female genital tract:a challenging question for gynaecologic oncologist and pathologist[J].Gynecol Oncol Rep,2020,33(1):100603.DOI:10.1016/j.gore.2020.100603.
[31]
Croce S,Devouassoux-Shisheboran M,Pautier P,et al.Uterine sarcomas and rare uterine mesenchymal tumors with malignant potential.Diagnostic guidelines of the French Sarcoma Group and the Rare Gynecological Tumors Group[J].Gynecol Oncol,2022,167(2):373-389.DOI:10.1016/j.ygyno.2022.07.031.
[32]
Natella V,Merolla F,Giampaolino P,et al.A huge malignant perivascular epithelioid cell tumor (PEComa)of the uterine cervix and vagina[J].Pathol Res Pract,2014,210(3):186-188.DOI:10.1016/j.prp.2013.10.003.
[33]
Gadducci A,Ugolini C,Cosio S,et al.Primary perivascular epithelioid cell tumor (PEComa)of the ovary:a case report and review of the literature[J].Anticancer Res,2021,41(9):4483-4488.DOI:10.21873/anticanres.15258.
[34]
Jiang Y,Liu X,Zhang S,et al.Risk stratification and outcomes in 210 gynecologic perivascular epithelioid cell tumors (PEComas)cases[J].Arch Gynecol Obstet,2023,307(3):681-687.DOI:10.1007/s00404-022-06470-y.
[35]
Sanfilippo R,Jones RL,Blay JY,et al.Role of chemotherapy,VEGFR inhibitors,and m TOR inhibitors in advanced perivascular epithelioid cell tumors(PEComas)[J].Clin Cancer Res,2019,25(17):5295-5300.DOI:10.1158/1078-0432.CCR-19-0288.
[36]
Sanfilippo R,Fabbroni C,FucàG,et al.Addition of antiestrogen treatment in patients with malignant PEComa progressing to m TOR inhibitors[J].Clin Cancer Res,2020,26(20):5534-5538.DOI:10.1158/1078-0432.CCR-20-1191.
[37]
Ferrari FA,Garzon S,CaliòA,et al.2022-RA-1535-ESGO uterine PEComa and prognostic value of the proposed classification systems:a retrospective study,systematic review,and Meta analysis[J].Int J Gynecol Cancer,2022,32(Sup2):2.DOI:10.1136/ijgc-2022-ESGO.461.
[1] 江敏, 陈爱华. 促性腺激素启动日多囊卵巢综合征不孕患者的促甲状腺激素水平与人体质量指数对其促排卵优质胚胎形成的交互作用[J/OL]. 中华妇幼临床医学杂志(电子版), 2025, 21(02): 171-179.
[2] 撒沙威, 马黔红. 子宫内膜种植窗口期及内膜微生物组与个体化胚胎移植的研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2025, 21(02): 140-144.
[3] 姚晓曦, 韦柳杏, 王瑞瑜, 李梦瑶, 刘清玉, 郄明蓉. 宫颈管搔刮术对阴道镜宫颈组织病理学结果为宫颈上皮内瘤变2级及以上患者术后病理升级为宫颈癌的预测价值[J/OL]. 中华妇幼临床医学杂志(电子版), 2025, 21(02): 157-164.
[4] 沈钰, 张步环, 黄祖金, 唐杰, 李世俊. 老年女性脊柱多发浆细胞瘤1例临床分析及文献复习[J/OL]. 中华妇幼临床医学杂志(电子版), 2025, 21(02): 237-244.
[5] 安春晓, 彭丽娜, 张献, 张广美. 微小RNA 与子宫内膜异位症的相关研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2025, 21(01): 73-77.
[6] 杨娟, 杜雪, 田旺, 吕文杰, 杨媛媛, 尹宗智. 子宫动脉栓塞术对阴道分娩后胎盘滞留及合并胎盘植入患者清宫术治疗胎盘滞留的疗效分析[J/OL]. 中华妇幼临床医学杂志(电子版), 2025, 21(01): 114-121.
[7] 张睿敏, 董哲毅, 王倩, 陈香美. 肾小管间质纤维化生物标志物研究进展[J/OL]. 中华肾病研究电子杂志, 2025, 14(02): 91-96.
[8] 章敏. 利用多组学技术筛选慢性肾脏病早期预警和预后标志物[J/OL]. 中华肾病研究电子杂志, 2025, 14(02): 120-120.
[9] 何许巍, 刘洋, 程庆砾, 敖强国. 急性肾损伤早期生物标志物即时检测的研究进展[J/OL]. 中华肾病研究电子杂志, 2025, 14(01): 48-52.
[10] 吕一帆, 张斌, 茆翔, 刘佰运, 高国一, 牛非. 定量蛋白质组学分析皮质酮对急性创伤性脑损伤的神经保护作用[J/OL]. 中华神经创伤外科电子杂志, 2025, 11(01): 17-25.
[11] 汪玥, 陆衡, 曹洁, 陆博文. GNG4蛋白在胃肠道间质瘤中的表达及预后意义[J/OL]. 中华消化病与影像杂志(电子版), 2025, 15(01): 6-10.
[12] 王美琴, 潘海涛, 陈祥菲, 吴婉, 周昱和, 王砚青. S100B 蛋白在心血管疾病中的研究进展[J/OL]. 中华临床医师杂志(电子版), 2025, 19(03): 229-233.
[13] 王颖, 杨焱焱, 牛雯晓, 李梦凡, 张金彪. 非体位性阻塞性睡眠呼吸暂停与认知功能障碍的相关性研究[J/OL]. 中华临床医师杂志(电子版), 2025, 19(02): 108-116.
[14] 张双, 樊清语, 田雅乐, 柏福运, 贾岩龙. 肝脏乏脂肪型血管周上皮样细胞肿瘤的影像学特征[J/OL]. 中华诊断学电子杂志, 2025, 13(02): 97-102.
[15] 石继开, 王平, 陈军. 基于胆固醇代谢相关基因构建前列腺癌复发的风险预测模型[J/OL]. 中华老年病研究电子杂志, 2025, 12(01): 22-29.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?